PDCD4 functions as a suppressor for pT2a and pT2b stage gastric cancer

Oncology Reports

Volumn 29, Issue 3, 2013, Pages 1007-1012

  Guo, Peng Tao ^a   Yang, Dong ^a   Sun, Zhe ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Gastric cancer; PDCD4; Survival analysis

Indexed keywords

MEMBRANE RECEPTOR; MESSENGER RNA; PROGRAMMED DEATH 4 RECEPTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL CYCLE G2 PHASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; SURVIVAL RATE; WESTERN BLOTTING;

ADENOCARCINOMA; AGED; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA-BINDING PROTEINS; STOMACH NEOPLASMS;

EID: 84872809851     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2232     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 9-90, 2011.
2. Sarela AI, Turnbull AD, Coit DG, et al: Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma. Ann Surg Oncol 10: 783-791, 2003. (Pubitemid 40486879)
3. Kunisaki C, Shimada H, Nomura M, et al: Distribution of lymph node metastasis in gastric carcinoma. Hepatogastroenterology 53: 468-472, 2006. (Pubitemid 43954429)
4. Potrc S, Gadiijev E, Hajdinjak T, et al: Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer. Hepatogastroenterology 54: 308-314, 2007. (Pubitemid 46511696)
5. Greene FL, Page DL, Fleming ID, et al (eds): AJCC Cancer Staging Manual. 6th edition. Springer-Verlag, New York, 2002.
6. Ebert M P, Fei G, Kahmann S, et al: Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 23: 87-91, 2002. (Pubitemid 34213556)
7. El-Rifai W and Powell SM: Molecular biology of gastric cancer. Semin Radiat Oncol 12: 128-140, 2002 (Pubitemid 34522349)
8. Cmarik JL, Min H, Hegamyer G, et al: Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 96: 14037-14042, 1999.
9. Soejima H, Miyoshi O, Yoshinaga H, et al: Assignment of the programmed cell death 4 gene (PDCD4) to human chromosome band 10q24 by in situ hybridization. Cytogenet Cell Genet 87: 113-114, 1999. (Pubitemid 30021050)
10. Afonja O, Juste D, Das S, et al: Induction of PDCD4 tumour suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23: 8135-8145, 2004. (Pubitemid 39531854)
11. Bitomsky N, Wethkamp N, Marikkannu R, et al: siRNA-mediated knockdown of PDCD4 expression causes upregulation of p21 (Waf1/Cip1) expression. Oncogene 27: 4820-4829, 2008.
12. Carayol N, Katsoulidis E, Sassano A, et al: Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway. J Biol Chem 283: 8601-8610, 2008.
13. Yoshinaga H, Matsuhashi S, Fujiyama C, et al: Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody. Pathol Int 49: 1067-1077, 1999. (Pubitemid 30193505)
14. Chen Y, Knosel T, Kristiansen G, et al: Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200: 640-646, 2003. (Pubitemid 36987314)
15. Mudduluru G, Medved F, Grobholz R, et al: Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 110: 1697-1707, 2007. (Pubitemid 47558956)
16. Zhang H, Ozaki I, Mizuta T, et al: Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25: 6101-6112, 2006. (Pubitemid 44562408)
17. Motoyama K, Inoue H, Mimori K, et al: Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol 36: 1089-1095, 2010.
18. Asangani IA, Rasheed SA, Nikolova DA, et al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136, 2008. (Pubitemid 351485639)
19. Wang X, Wei Z, Gao F, et al: Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma. Anticancer Res 28: 2991-2996, 2008.
20. Gao F, Wang X, Zhu F, et al: PDCD4 gene silencing in gliomas is associated with 5'CpG island methylation and unfavourable prognosis. J Cell Mol Med 13: 4257-4267, 2009.
21. Shibahara K, Asano M, Ishida Y, et al: Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166: 297-301, 1995.
22. Zhang Z and DuBois RN: Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 20: 4450-4456, 2001. (Pubitemid 32772427)